Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-24 Sale | 2019-05-29 8:00 pm | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 82,596 | $15.32 | $1,265,083 | 27,505 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-01 Option Award | 2022-07-01 5:02 pm | 2023-07-01 2032-07-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 710,711 | $0 | 710,711 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:02 pm | 2022-07-01 2031-07-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 379,788 | $0 | 379,788 (Direct) | View |
| 2021-05-05 Disposition | 2021-05-07 4:15 pm | N/A 2027-01-06 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 166,572 | $0 | 0 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 6:44 pm | N/A 2031-02-22 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 22,464 | $0 | 22,464 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-01 5:08 pm | 2021-07-01 2030-07-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 179,785 | $0 | 179,785 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:05 pm | N/A 2030-06-04 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 34,416 | $0 | 34,416 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-01 7:06 pm | 2021-04-01 2030-04-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 68,117 | $4.8641 | 27,505 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 14,479 | $0.0013 | 27,505 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | 2018-12-29 2025-12-29 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 82,596 | $0 | 27,505 (Direct) | View |
| 2019-05-16 Exercise | 2019-05-17 6:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Noble James Chief Executive Officer | 1,773,100 | $0.143 | 14,718,800 (Direct) | View |